Human Metapneumovirus (HMPV)

Source:  TOI

 Context: Amid concerns surrounding the outbreak of Human Metapneumovirus (HMPV) in China, Dr. Atul Goel, Director-General of Health Services, has assured the public that there is no need for alarm and urged people to follow basic precautions to stay safe.

About Human Metapneumovirus (HMPV):

  • What is HMPV?
    • Human Metapneumovirus (HMPV) is a respiratory virus first identified in 2001, belonging to the Pneumoviridae family. It causes upper and lower respiratory tract infections, typically manifesting symptoms akin to the common cold or flu.
  • Origin and Discovery:
    • HMPV was discovered in the Netherlands in 2001 through genomic sequencing of samples from patients with respiratory infections.
  • Who is at Risk?
    • Children under 5, particularly infants.
    • Older adults (65+).
    • Immunocompromised individuals and those with chronic respiratory conditions, like asthma.
  • Symptoms:
    • Common: Cough, runny nose, fever, sore throat.
    • Severe: Wheezing, shortness of breath, leading to bronchitis or pneumonia.
  • Mode of Spread:
    • Droplets from coughing/sneezing.
    • Close contact, including handshakes.
    • Contaminated surfaces, followed by touching the face.
  • Treatment:
    • No specific antiviral or vaccine.
    • Symptom management: Hydration, rest, Over the Counter (OTC) medications for fever and congestion.
    • Severe cases: Hospitalization for oxygen therapy or Intravenous (IV) fluids.
  • Diagnosis:
    • NAATs (Nucleic Acid Amplification Tests) to detect viral genetic material.
    • Antigen-based immunoassays for severe cases or outbreaks.

Insta links: